MEN1 and pituitary tumor: Indeed, gene replacement therapy using an adenoviral vector containing Men1 cDNA that was delivered directly to the pituitary tumours of Men1+/− mice, restored menin expression in the pituitary tumours and reduced their proliferation, without significant adverse effects or increased mortality (Walls et al., 2012).